Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis.
帕博利珠单抗和卡博替尼治疗复发和/或转移性头颈部鳞状细胞癌:生物标志物分析的长期生存率更新
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-1202
Saba Nabil F, Chaudhary Ritu, Kirtane Kedar, Marra Angelo, Ekpenyong Asari, McCook-Veal Ashley, Schmitt Nicole C, Gross Jennifer H, Patel Mihir R, Remick Jill, Bates James E, McDonald Mark W, Rudra Soumon F, Stokes William A, Biernacki Maria, Song Xiaofei, Slebos Robbert J C, Liu Yuan, Steuer Conor E, Shin Dong M, Teng Yong, Chung Christine H